美 트럼프 "다음주 코로나 백신 배송시작"... 아스트라제네카 글로벌 임상시험 시작<br /><br />UK pharmaceutical company AstraZeneca is going to do an extra trial to confirm the efficacy of their vaccine, which has been called into question.<br />This as President Donald Trump says vaccine deliveries for Americans will happen as early as next week.<br />Choi Won-jong with the details.<br />President Trump said Thursday that vaccines will start to be delivered next week... and the week after.<br />Speaking to troops on a video link for Thanksgiving,... he said that the first to get them... would be front-line workers, medical personnel and senior citizens.<br />In the UK, the pharmaceutical company AstraZeneca... is planning an extra global trial for its vaccine.<br />They're hoping to clear some unanswered questions for the world... after the company said the positive results of its trials so far... may have been affected by an error.<br />The company's CEO said on Thursday... that AstraZeneca wants the extra study to confirm the 90-percent efficacy rate.<br />The additional trial is not expected to hold up approvals in the U.K. or the EU,... and it's seen as a positive sign that the vaccine will ultimately be safe.<br />"The study they’ve shown does not mean that it has failed. It just means that we cannot use it because it did work for a lot of people who were injected with it. So the group that received two full doses that showed 62-percent of the efficacy, it still means that it’s usable, but with larger number of participants."<br />He recommended that the new study include at least 30-thousand participants.<br />Meanwhile, the South Korean government continues working to secure enough vaccines by negotiating with the companies behind all five existing candidates.<br />Officials say they'll disclose detailed information about vaccine supplies to the public as soon as possible... hoping to do so by early December.<br />Choi Won-jong, Arirang News.<br />